Enquire Now
Please Contact Us

toll free: 1800 3070 6727    Email: info@positivebioscience.com

BRACAnalysis CDx is an US-FDA approved companion diagnostic test for Ovarian cancer patients looking to get treated with a  PARP inhibitor. It covers BRCA1 and BRCA2 genes.Test is conducted on FFPE tumor blocks which is much more accurate than testing on blood.

  • My mother had ovarian cancer. After taking cisplatin we were looking for a therapy to maintain her response. We underwent BRACAnalysisCDX which was positive in her case  and we started giving her Olaparib.

  • s


Reports provides information that allows physicians to:

  • Better understand a patients’ risk for specific health conditions

  • Prescribe more suitable medications at optimal dosages for patients, as needed.

  • Suggest early lifestyle and diet interventions to help control or prevent certain health conditions.

Related Test

  • protect-25

    Best treatment recommendation

    Provides information on pathway analysis

    Includes Positive Bioscience expert comments and complementary consulation with your docto

    For further information

  • myrisk

    65% increase in median overall survival

    Multiple technology platform to provide most comprehensive recommendations

    Complimentary consultation

    For further information

  • health_plus

    31% more accurate in identifying cancer driver mutations

    Better treatment recommendation

    Complementary consultation with your doctor

    For further information

Copyright ©2017 Positive Biosciences, Ltd. All Rights Reserved

Disclaimer: All tests are not available in all regions. Certain tests require a doctor's prescription. Pricing and descriptions are subject to change without notice.